| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/04/2004 | EP1076650B1 Aryl fused azapolycyclic compounds |
| 02/04/2004 | EP1035859B1 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |
| 02/04/2004 | EP0992495B1 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0684816B1 5-ht2 receptor antagonists for treating venous conditions |
| 02/04/2004 | CN1473163A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473148A Novel crystals of N-hydroxy-2(S)-methyl-5-ethoxymethoxy-4(S)-[N-(4- phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing crystals as active ingredient |
| 02/04/2004 | CN1473144A Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride |
| 02/04/2004 | CN1473050A Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 02/04/2004 | CN1473046A Improved treatment |
| 02/04/2004 | CN1473042A Medical compositions |
| 02/04/2004 | CN1472337A Reagent box, method software and composite medicine for predicting effect of ACEI hypotensors |
| 02/04/2004 | CN1472325A Cardiac atrium peptide gene transfecting cell microcapsule |
| 02/04/2004 | CN1472214A Composition of ginkgo internal ester B and its preparation and use thereof |
| 02/04/2004 | CN1471971A Use of recombined human granulocyte colony stimulating factor in preparation of medicine for myocardiac infarction |
| 02/04/2004 | CN1471946A Chinese compound preparation for preventing atherosclerosis and preparing method thereof |
| 02/04/2004 | CN1471941A Chinese medicine haemorrhoids ointment |
| 02/04/2004 | CN1471936A Apoplexia hemiplegic recovered capsule and preparing method thereof |
| 02/04/2004 | CN1471932A Medicine for transient cerebral ischemia attack and its preparation |
| 02/04/2004 | CN1471928A Chinese patent drug for treating primary hypopiesi |
| 02/04/2004 | CN1471912A Oral film agent of vanadium biguanide complex for diabetes and its use |
| 02/04/2004 | CN1471911A Oral film agent of vanadium biguanide complex for diabetes and its use |
| 02/04/2004 | CN1471909A High-capacitance |
| 02/04/2004 | CN1471902A River points line and its production and use for curing coronary, diabetes and enterogastric ulcers |
| 02/04/2004 | CN1471865A Blood pressure reduced vinegar honey |
| 02/04/2004 | CN1471846A Healthy food for balancing blood pressure and regulating blood fat and preparing method thereof |
| 02/04/2004 | CN1137125C Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 02/04/2004 | CN1137123C Azolo triazizes and pyrimidines |
| 02/04/2004 | CN1137115C Process for extracting flavone from pomelo peel |
| 02/04/2004 | CN1137097C Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 02/04/2004 | CN1136920C Gene transfer-mediated angiogenesis therapy |
| 02/04/2004 | CN1136895C Medicine for treating coronary heart disease |
| 02/04/2004 | CN1136891C Freeze dried compound queen bee powder |
| 02/04/2004 | CN1136884C Diseases-resistant skin-protecting cream |
| 02/04/2004 | CN1136878C Combined Chinese Western medicine for treating cardiopulmonary disease in catabasis |
| 02/04/2004 | CN1136863C Chinese medicine for treating cerebral arteriosclerosis and its preparing process |
| 02/04/2004 | CN1136857C Traditional Chinese medicine external preparation for curing piles |
| 02/03/2004 | US6686484 Anticoagulants; serine protease inhibitor |
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686397 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 02/03/2004 | US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 02/03/2004 | US6686384 2-anilinophenyl-substituted; inhibition of the na+/h+ exchanger |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686381 Compounds that antagonize neuropeptide y at the y5 receptor subtype represent an approach to the treatment of eating disorders such as obesity and hyperphagia |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686369 α-hydrdroxylic acid derivatives, their production and use |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686362 Indolinone derivatives |
| 02/03/2004 | US6686360 N-benzylpiperazine compounds |
| 02/03/2004 | US6686358 Anticoagulants; cardoviscular disorders |
| 02/03/2004 | US6686356 Pyridoquinoxaline antivirals |
| 02/03/2004 | US6686355 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 02/03/2004 | US6686354 Agonists and antagonists of peripheral-type benzodiazepine receptors |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6686349 Administering to a patient for the treatment of sexual dysfunction an effective amount of substituted tetracyclic pyrroloquinolone derivatives |
| 02/03/2004 | US6686348 Metalloprotease inhibitors |
| 02/03/2004 | US6686347 Phthalazine derivatives for treating inflammatory diseases |
| 02/03/2004 | US6686343 Triazolopurine derivatives, pharmaceutical compositions containing the derivatives, and adenosine A3 receptor affinitive agents |
| 02/03/2004 | US6686341 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 02/03/2004 | US6686337 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 02/03/2004 | US6686335 Hydroxamate-containing cysteine and serine protease inhibitors |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | CA2128876C Triazolopyrimidine derivatives as angiotensin ii receptor antagonists |
| 02/03/2004 | CA2067151C Aica riboside analogs |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/31/2004 | CA2396350A1 Methods of identifying selective .beta.-1-adrenergic receptor antagonists |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009800A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009641A1 aPC NON-NEUTRALIZING ANTIBODY |
| 01/29/2004 | WO2004009620A1 Novel na+/h+ exchanger inhibitor peptide (pinhe) and applications thereof |
| 01/29/2004 | WO2004009603A1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 01/29/2004 | WO2004009602A1 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |
| 01/29/2004 | WO2004009596A2 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009594A2 Xanthine derivatives having adenosine a1-receptor antagonist properties |
| 01/29/2004 | WO2004009592A1 Bicyclic unsaturated tertiary amine compound |
| 01/29/2004 | WO2004009588A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009585A2 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors |
| 01/29/2004 | WO2004009582A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | WO2004009579A1 Novel compounds |
| 01/29/2004 | WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 01/29/2004 | WO2004009575A1 An extract of a typhae pollen and its manufacture and use |
| 01/29/2004 | WO2004009565A2 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009560A1 Novel bio-active molecules |
| 01/29/2004 | WO2004009556A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 01/29/2004 | WO2004009550A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1 |
| 01/29/2004 | WO2004009547A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009546A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 01/29/2004 | WO2004009541A2 Antisense modulation of endothelial lipase expression |
| 01/29/2004 | WO2004009537A1 NOVEL α-KETOAMIDE DERIVATIVE AND USE THEREOF |
| 01/29/2004 | WO2004009521A1 Remedy |
| 01/29/2004 | WO2004009132A1 Selected cell delivery for heart failure |
| 01/29/2004 | WO2004009122A1 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |